Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus

INTRODUCTION: Patients with systemic lupus erythematosus (SLE) have persistent platelet activation and an increased risk of thrombotic events, which cannot be accounted for by traditional cardiovascular risk factors. Factor (F)XII has a potentially important role in thrombus formation and is trigger...

Descripción completa

Detalles Bibliográficos
Autores principales: Bäck, Jennie, Lood, Christian, Bengtsson, Anders A, Ekdahl, Kristina Nilsson, Nilsson, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979000/
https://www.ncbi.nlm.nih.gov/pubmed/24299152
http://dx.doi.org/10.1186/ar4399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979000/
https://www.ncbi.nlm.nih.gov/pubmed/24299152
http://dx.doi.org/10.1186/ar4399

Ejemplares similares